| Literature DB >> 29855444 |
Dorien De Strijcker1, Bruno Lapauw, D Margriet Ouwens, Dominique Van de Velde, Dominique Hansen, Mirko Petrovic, Claude Cuvelier, Cajsa Tonoli, Patrick Calders.
Abstract
OBJECTIVES: To evaluate the effect of high intensity training (HIT) on physical fitness, basal respiratory exchange ratio (bRER), insulin sensitivity and muscle histology in overweight/obese men compared to continuous aerobic training (CAT).Entities:
Mesh:
Year: 2018 PMID: 29855444 PMCID: PMC6016496
Source DB: PubMed Journal: J Musculoskelet Neuronal Interact ISSN: 1108-7161 Impact factor: 2.041
Details of the two different exercise training modes.
| Training modus | Warming up (5’) | Cycling (10’) | Stepping or cycling (10’) | Cycling (10’) | Cooling down (5’) |
|---|---|---|---|---|---|
| Stretching + Aerobic exercise lower and upper limb (30% of peak watt) | 10 sprint bouts: 15” (100 rounds per minute) at 100% resistance at ventilatory threshold (week 1-5) increasing to 110% resistance at ventilatory threshold (week 6-10) + 45” (40-60 rpm) at 50% ventilatory threshold (week 1-5) increasing to 55% ventilatory threshold (week 6-10) | Continuous (60 rounds per minute) 100% of heart rate at ventilatory (week 1 to 5) and 110% of heart rate at ventilatory (week 6 to 10) | 10 sprint bouts: 15” (100 rounds per minute) at 100% resistance at ventilatory threshold (week 1-5) increasing to 110% resistance at ventilatory threshold (week 6-10) + 45” (40-60 rounds per minute) at 110% resistance at ventilatory threshold (week 1-5) increasing to 110% resistance at ventilatory threshold (week 6-10) | Stretching + Aerobic exercise lower and upper limb (30% of peak watt) | |
| 5 min Idem HIT | continuous (60 rounds per minute) 100%of heart rate at ventilatory threshold (week 1 to 5) and 110% of heart rate at ventilatory threshold (week 6 to 10) | continuous (60 rounds per minute) 100% of heart rate at ventilatory threshold (week 1 to 5) and 110% of heart rate at ventilatory threshold (week 6 to 10) | continuous (60 rounds per minute) 100% of heart rate at ventilatory threshold (week 1 to 5) and 110% of heart rate at ventilatory threshold (week 6 to 10) | 5 min Idem HIT |
HIT: high intensity training; CAT: continuous aerobic training; rpm: rounds per minute.
Figure 2Transmission electron microscopy showing the presence of mitochondria and intramyocellular lipid droplets in the intramyofibrillar and subsarcollemal space of a biopsy of the vastus lateralis muscle of males with overweigth or obesity participating in an exercise training program (continuous aerobic training (CAT) or high intensity training (HIT)).
A: Transmission electron microscopy picture showing mitochondria (mito) and intramyocellular lipid droplets (IMCL) in the intramyofibrillar (IMF) and subsarcollemal (SS) space. The space between 2 Z-lines is the sarcomere. The black line is an imaginary line between IMF and SS. The space below the sarcolemma (SarcoL) is the SS. (x12.000 original magnification).
Figure 2B and CTransmission electron microscopy picture showing mitochondria (mito) in the intramyofibrillar (IMF) space. The space between 2 Z-lines is the sarcomere. Picture B is a muscle sample before the start of HIT. Picture C Is a muscle sample after 10 weeks of HIT showing larger surface area. (x12.000 original magnification).
Anthropometric data and exercise capacity of the participants at baseline and after the training period for each intervention group.
| Parameters | CAT pre | CAT post | HIT pre | HIT post | P-value (interaction effects) |
|---|---|---|---|---|---|
| Age (year) | 46.0 (5.6) | 46.0 (5.6) | 47.0 (3.4) | 47.0 (3.4) | 0.92 |
| Height (cm) | 174.5 (4.0) | 174.5 (4.0) | 175.8 (6.8) | 175.8 (6.8) | 0.99 |
| Weight (kg) | 101.6 (16.7) | 100.4 (16.7) | 98.7 (12.6) | 97.6 (13.2) | 0.73 |
| BMI (kg/m2) | 33.0 (5.7) | 32.6 (5.7) | 31.9 (5.6) | 31.3 (5.7) | 0.88 |
| Respiratory exchange ratiomax | 1.16 (0.05) | 1.15 (0.08) | 1.17 (0.06) | 1.16 (0.05) | 0.85 |
| Peak VO2 (l/min) | 2.9 (0.6) | 3.0 (0.6) | 2.9 (0.6) | 3.1 (0.5) | 0.004 |
| Rel.peakVO2 (ml/kg/min) | 30.3 (9.4) | 30.5 (9.8) | 30.9 (7.5) | 32.9 (7.2) | 0.011 |
| Peak cycling power output (watt) | 218 (57) | 228 (60) | 240 (50) | 274 (50) | <0.001 |
| Peak heart rate (beats/min) | 163 (19) | 162 (19) | 163 (16) | 161 (18) | 0.41 |
| VO2 at ventilatory threshold (l/min) | 2.3 (0.5) | 2.4 (0.5) | 2.2 (0.5) | 2.6 (0.5) | 0.009 |
| Cycling Power output at ventilatory threshold (Watt) | 171 (46) | 173 (45) | 168 (43) | 206 (50) | 0.002 |
| HR at ventilatory threshold (beats/min) | 139 (15) | 135 (13) | 140 (23) | 145 (20) | 0.10 |
Data are expressed as mean (standard deviation). Significance level is set at P<0.05. Data were statistically evaluated by repeated measures ANCOVA (covariate OGTT) post hoc Bonferroni. Interaction effects are mentioned in the last column (P-value). The post hoc Bonferroni to evaluate time effects within each group are mentioned by * and .
= P<0.05: CATpre versus CATpost;
= P<0.05: HITpre versus HITpost. // BMI= body mass index. PeakVO2= oxygen consumption at peak level; relpeakVO2 = oxygen consumption at peak level expressed per body weight.
Basal respiratory exchange ratio and insulin sensitivity of the participants at baseline and after the training period for each intervention group.
| Parameters | CAT pre | CAT post | HIT pre | HIT post | P-value (between group) |
|---|---|---|---|---|---|
| Basal respiratory exchange ratio | 0.82 (0.03) | 0.84 (0.04) | 0.85 (0.03) | 0.79 (0.04) | <0.001 |
| Fasting plasma glucose(mg/dl) | 99.1 (11.2) | 99.5 (9.3) | 102.1 (8.8) | 96.4 (10.7) | 0.117 |
| Fasting plasma insulin (µU/ml) | 15.8 (5.4) | 15.7 (7.9) | 21.0 (5.4) | 14.3 (8.5) | 0.002 |
| Area under the curve of glucose (mg/dl) | 143.9 (30.6) | 137.0 (23.7) | 191.1 (32.6) | 152.1 (39.7) | <0.001 |
| Area under the curve of insulin (µU/ml) | 184.9 (41.5) | 179.4 (40.4) | 286.1 (96.1) | 197.1 (82.8) | <0.001 |
Data are expressed as mean (standard deviation). Significance level is set at P<0.05. Data were statistically evaluated by repeated measures ANCOVA (covariate OGTT) post hoc Bonferroni. Interaction effects are mentioned in the last column (P-value). The post hoc Bonferroni to evaluate time effects within each group are mentioned by * and #.
=P<0.05: CATpre versus HITpre; *= P<0.05: CATpre versus CATpost;
= P<0.05: HITpre versus HITpost.
Number (n) and surface (s) of lipid droplets and mitochondrial subsarcollemal and intramyofibrillar site of the participants at baseline and after the training period for each intervention group.
| CATpre (n=8) | CATpost (n=8) | HITpre (n=8) | HITpost (n=8) | P-value (interaction effects) | |
|---|---|---|---|---|---|
| Intramyfibrillarlipid (number) | 40 (24) | 53 (33) | 79 (52) | 154 (101) | 0.002 |
| Subsarcollemallipid (number) | 13 (2) | 12 (2) | 13 (10) | 20 (14)# | 0.007 |
| IntramyfibrillarMito (number) | 130 (12) | 127 (12) | 106 (23) | 182 (46) | <0.001 |
| SSmito (n) | 63 (20) | 63 (15) | 40 (16) | 82 (25) | 0.001 |
| Intramyfibrillarlipid (su) | 21.7 (13.6) | 31.1 (20.7) | 24.4 (15.7) | 51.5 (20.9) | 0.043 |
| Subsarcollemallipid (surface) | 6.8 (2.1) | 7.7 (2.6) | 5.7 (3.0) | 6.9 (3.3) | 0.716 |
| IntramyfibrillarMito (su) | 21.7 (3.4) | 20.8 (2.3) | 17.6 (7.0) | 25.7 (7.3) | 0.002 |
| Subsarcollemallipid (surface) | 12.7 (4.0) | 12.4 (2.6) | 6.0 (2.7) | 15.2 (8.5) | 0.008 |
Data are expressed as mean (standard deviation). Significance level is set at P<0.05. Data were statistically evaluated by repeated measures ANCOVA (covariate OGTT) post hoc Bonferroni. Interaction effects are mentioned in the last column (P-value). Baseline differences between HIT and CAT are mentioned by
: p<0,05. The post hoc Bonferroni to evaluate time effects within each group are mentioned by * and #.
= P<0.05: CATpre versus CATpost;
= P<0.05: HITpre versus HITpost.
Association between changes in metabolic, physical and histological parameters in the total group (combined CAT and HIT).
| (n=16) | Delta oral glucose tolerance test (r-value) | P-value |
|---|---|---|
| deltapeakVO2 | 0.474 | 0.06 |
| deltarelpeakVO2 | 0.436 | 0.09 |
| Delta respiratory exchange ratio | -0.740 | 0.001 |
| Delta intramyfibrillar lipid (number) | 0.294 | 0.27 |
| Delta intramyofibrillar lipid (surface) | 0.300 | 0.26 |
| Delta subsarcollemal lipid (number) | 0.318 | 0.23 |
| Delta subsarcollemal lipid (surface) | 0.172 | 0.52 |
| Delta intramyofibrillar mitochondria (number) | 0.462 | 0.07 |
| Delta intramyofibrillar mitochondria (surface) | 0.540 | 0.031 |
| Delta subsarcollemal mitochondria (number) | 0.540 | 0.031 |
| Delta subsarcollemal mitochondria (surface) | 0.364 | 0.08 |
Data were statistically evaluated by Pearson correlation coefficients (r-value). Significance level is set at P<0.05. Delta= pre-post of each parameter. PeakVO2 = oxygen consumption at peak level; relpeak VO2 = oxygen consumption at peak level expressed per body weight.